BENGALURU, June 27 (Reuters) - More than 36% of the 400 drug manufacturing units inspected since last year in India were ordered to be shut, the country's drug regulator said on Thursday, after deaths ...
New Delhi, Jul 22 (PTI) Since 2022, 905 firm units have been inspected, resulting in actions being taken against 694 of those firms based on risk criteria like the number of drugs declared as not of ...
Feb 27 (Reuters) - The U.S. drug regulator is set to increase the number of inspections at Indian drug manufacturing units in 2024 amid growing concerns over the quality of drugs, a top executive for ...
CHENNAI: Routine inspections were not conducted at Sresan Pharmaceutical unit in Kancheepuram, the manufacturer of the Coldrif cough syrup linked to the deaths of children in Madhya Pradesh, officials ...